Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Clinical Medicine Insights. Oncology|July 12, 2016
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical PracticeFabien Calcagno, Sabrina Lenoble, Zaher Lakkis, et al.
Frontiers in Oncology|December 5, 2022
Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinomaLaure Hervé, Stefano Kim, Jihane Boustani, et al.
Lab on a Chip|July 17, 2023
Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assaysClémentine Lipp, Laure Koebel, Romain Loyon, et al.
Journal of Clinical Pathology|September 30, 2010
Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trialFranck Monnien, Harouna Zaki, Christophe Borg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 12, 2025
Characterization and clinical outcomes of rare biliary adenosquamous carcinomaAnne Ruffat, Franck Monnien, Chloé Molimard, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2019
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II studyFrancois Ghiringhelli, Julie Vincent, Leila Bengrine, et al.
Journal of Immunological Methods|December 17, 2014
Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donorsAnne-Pauline Bellanger, Jean-René Pallandre, Houssein Gbaguidi-Haore, et al.
Journal for Immunotherapy of Cancer|April 26, 2022
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?Syrine Abdeljaoued, Sara Arfa, Marie Kroemer, et al.
Oncology Reports|January 19, 2017
Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumorsDavid Guenat, Olivier Deroo, Sandrine Magnin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2023
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysisCaroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, et al.
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Clinical Medicine Insights. Oncology|July 12, 2016
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical PracticeFabien Calcagno, Sabrina Lenoble, Zaher Lakkis, et al.
Frontiers in Oncology|December 5, 2022
Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinomaLaure Hervé, Stefano Kim, Jihane Boustani, et al.
Lab on a Chip|July 17, 2023
Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assaysClémentine Lipp, Laure Koebel, Romain Loyon, et al.
Journal of Clinical Pathology|September 30, 2010
Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trialFranck Monnien, Harouna Zaki, Christophe Borg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 12, 2025
Characterization and clinical outcomes of rare biliary adenosquamous carcinomaAnne Ruffat, Franck Monnien, Chloé Molimard, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2019
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II studyFrancois Ghiringhelli, Julie Vincent, Leila Bengrine, et al.
Journal of Immunological Methods|December 17, 2014
Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donorsAnne-Pauline Bellanger, Jean-René Pallandre, Houssein Gbaguidi-Haore, et al.
Journal for Immunotherapy of Cancer|April 26, 2022
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?Syrine Abdeljaoued, Sara Arfa, Marie Kroemer, et al.
Oncology Reports|January 19, 2017
Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumorsDavid Guenat, Olivier Deroo, Sandrine Magnin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2023
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysisCaroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, et al.
Pageof 23